Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2019

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • K Offline
    K Offline
    kkjoel
    wrote on sidst redigeret af
    #883

    Jeg synes egentlig dagen er fuld af lyspunkter.... i går kom superfine recepttal og GEN steg efterfølgende pænt. DEN markedsreaktion viser at markedsdeltagerne - trods alt - godt kan forstå at vi er trygt på vej.. way henover guidance for 2019! Det faktum giver mig glimmer for øjnene i ugevis 🙂 🙂

    1 Reply Last reply
    0
    • nohopeN Offline
      nohopeN Offline
      nohope
      wrote on sidst redigeret af
      #884

      We are not amused.

      1 Reply Last reply
      0
      • K Offline
        K Offline
        kkjoel
        wrote on sidst redigeret af
        #885

        Mer vil have mer.... slap af! 😉

        1 Reply Last reply
        0
        • K Offline
          K Offline
          kkjoel
          wrote on sidst redigeret af
          #886

          Læn dig tilbage, tillad dig at håbe på en bedre fremtid.. vær behageligt fornøjet... og tænk sig: we are not confused.

          1 Reply Last reply
          0
          • P Offline
            P Offline
            polle1
            wrote on sidst redigeret af
            #887

            kkjoel : tommel op... 😉

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #888

              God morgen. 🙂

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bibob
                wrote on sidst redigeret af
                #889

                God morgen. 🙂

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bibob
                  wrote on sidst redigeret af
                  #890

                  GSK / BCMA drug med gode resultater. https://m.firstwordpharma.com/glaxosmithkline-targets-regulatory-filings-year-end-anti-bcma-drug-gsk2857916-multiple-myeloma

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #891

                    "
                    Meanwhile, among Darzalex-experienced patients, the drugmaker said the ORR and median PFS were 38.5 percent and 7.9 months, respectively. GlaxoSmithKline noted that no new safety signals were observed in the study".

                    1 Reply Last reply
                    0
                    • T Offline
                      T Offline
                      transalp
                      wrote on sidst redigeret af
                      #892

                      Go morgen : )

                      1 Reply Last reply
                      0
                      • StockBullS Offline
                        StockBullS Offline
                        StockBull
                        wrote on sidst redigeret af
                        #893

                        🙂 Morn. Rısıng wedge ındıkere bullısh stıgnıng mod / gennem modstanden ı 1189

                        1 Reply Last reply
                        0
                        • J Offline
                          J Offline
                          jkj
                          wrote on sidst redigeret af
                          #894

                          hvis det er direkte sammenlignelige tal, så er det vel ikke så godt for dara. ?

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            polle1
                            wrote on sidst redigeret af
                            #895

                            Godmorgen og god dag 🙂

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #896

                              read back the nov Q3 transcript back, answer to Citi analyst on BCMA. eg: Jan: actually, we were actually delighted to see the updated data. We don't feel very threatened by them at all

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #897

                                "And what is also encouraging is that Janssen recently, they also have a BCMA CD3 bispecific program using our DuoBody technology….& said in the business update that they intend to actually combine their BCMA CD3 bispecific together with daratumumab and not compete with daratumumab, and that is probably the right thing to do also for the BCMA ADC from Glaxo and potentially for Amgen's BCMA BiTE molecule."

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  peter12
                                  wrote on sidst redigeret af
                                  #898

                                  Det var det EL linkede til i onsdags. Det er et lille studie (n=35) og kun friske patienter, da det nok er for giftigt til svagere...

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #899

                                    Tak for reminderen E L. 🙂

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      gentogen
                                      wrote on sidst redigeret af
                                      #900

                                      Lidt svært helt at gennemskue, men 54% af patienterne var "Stage I" og alle ECOG 0 eller 1 (70% 1). Tidligere behandlinger fra 1 til over 10. 14 en eller anden slags Dara behandling tidligere. Safety lidt svær at vurdere da procenterne er procenter af alle, selv om kun 22 af 35 gennemførte (så tallene kan være for små - måske). De fremhæver selv at dette er det hidtil bedste, der er set efter Dara

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #901

                                        Link Preview Image
                                        Genmab Announces European Regulatory Submission for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma

                                        Company Announcement Type II variation application submitted to the EMA for daratumumab in combination with lenalidomide and dexamethasone as treatment...

                                        favicon

                                        GlobeNewswire News Room (www.globenewswire.com)

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #902

                                          Genmab Announces European Regulatory Submission for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger